Skip to main content
. 2017 Apr 20;9(1):6976. doi: 10.4081/dr.2017.6976

Figure 1.

Figure 1.

Pruritic rash in Waldenstrom's patient developed 12 weeks after beginning Ibrutinib therapy. A) Upper back; B) back thighs and calves; C and D) close-up of rash papules seen in panels A and B.